About
Our investigational therapies target rare diseases through three modalities: gene replacement, exon skipping gene therapy and vectorized RNA knockdown. We are leveraging Astellas’ global resources, industry leadership in immune biology, and deep scientific expertise to expand our reach and develop valuable new genetic medicines for patients around the world. We invite you to explore more about Astellas Gene Therapies and career opportunities by visiting:
https://www.astellasgenetherapies.com/
www.astellasgenetherapies.com/careers/